← All stocks

Actinium Pharmaceuticals, Inc.

ATNM Net buying

CIK 0001388320 #4864 in the set updated 21 Sep 2026

Bought (120 mo)

$98.96K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$98.96K

+$98.96K against sales at will

By person

10 insiders · 17 transactions

1.1×

Sandesh Seth holds only 1.1 times base salary in stock. $854.93K of shares against $733.20K in salary for 2024.

Salary from the company's own proxy. The shares are what Sandesh Seth last reported holding, valued at $0.44, the price Common Stock was last bought or sold at on the open market here, on 10 Dec 2018.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

SETH SANDESH

Chief Executive Officer

$57.20K (8)

—

+$57.20K

1,965,355

6.25%

$854.93K

—

O'Loughlin Steve

Chief Financial Officer

$14.45K (3)

—

+$14.45K

35,500

0.1129%

$15.44K

—

Shetty Ajit

Director

$9.77K (1)

—

+$9.77K

62,357

0.1983%

$27.13K

—

Ray Nitya G.

Executive VP

$7.50K (1)

—

+$7.50K

20,000

0.0636%

$8.70K

—

Berger Mark Stanley

Chief Medical Officer

$5.55K (1)

—

+$5.55K

22,500

0.0716%

$9.79K

—

Ludwig Dale L.

Chief Science & Tech. Officer

$4.50K (1)

—

+$4.50K

10,000

0.0318%

$4.35K

—

Nicholson, C. David

Director

—

63,300

0.2013%

$27.54K

+12,560%

Steinhart Richard I

Director

—

63,116

0.2007%

$27.46K

—

Chell Jeffrey W.

Director

—

61,600

0.1959%

$26.80K

—

Almenoff June Sherie

Director

—

18,000

0.0572%

$7.83K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 86

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 2,573,699

History held since 1 Sep 2016